Marker Therapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Marker Therapeutics Inc.
Former names: Tapimmune INC. Genemax Corp Eduverse COM
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Houston
Headquarters state / province: Texas
Headquarters country: United States
Fiscal year end: December
Ticker symbol: MRKR
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001094038
EIN: 88-0277072

Board of directors

Follow this board

John Robert Wilson · Director
Since 2023
Juan Vera · Director · Chief Executive Officer
Since 2023
Katharine Knobil · Director
Since 2023
Kathryn Penkus Corzo · Director
Since 2025
Norman David Eansor · Director
Since 2023
Steve Elms · Director
Since 2023

Chief executives

Juan Vera · President and CEO

Dates unknown

Director election results

Annual meeting of May 1, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Shared director Other board Same sector

ADMA Biologics Inc Same sector
via Steve Elms
Kalaris Therapeutics Inc. Same sector
via Juan Vera
Korro Bio Inc. Same sector
via Katharine Knobil
Matinas Biopharma Holdings Inc. Same sector
via Kathryn Penkus Corzo
Pliant Therapeutics Inc. Same sector
via Katharine Knobil

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Dec 23, 2024	Steve Elms Director	Open-market purchase	+11,085	$3.20	$35,472
Dec 23, 2024	NEA Partners 16, L.P. 10% owner	Open-market purchase	+554,250	$3.20	$1,773,600
Mar 25, 2021	Norman David Eansor Director	Gift	−14,285	—	—
Mar 25, 2021	Norman David Eansor Director	Gift	+7,142	—	—
Mar 25, 2021	Norman David Eansor Director	Gift	+7,142	—	—
Mar 16, 2021	Norman David Eansor Director	Open-market purchase	+14,285	$17.50	$249,988

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Marker Therapeutics Inc.

Who is the CEO of Marker Therapeutics Inc.?

Juan Vera is Marker Therapeutics Inc.'s President and CEO.

How many directors are on Marker Therapeutics Inc.'s board?

Marker Therapeutics Inc.'s board has 6 directors: John Robert Wilson, Juan Vera, Katharine Knobil, Kathryn Penkus Corzo, Norman David Eansor and Steve Elms.

How is Marker Therapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="marker-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.